PHARMACY

Meghann Chilcott, formerly of OrderInsite, is joining Benzer Pharmacy as its chief technology and marketing officer.

Aurobindo is entering the branded oncology injectable space via an acquisition from Spectrum Pharmaceuticals.

Hamacher's Rx Track-and-Trace Compliance Services include multiple components to help pharmacies meet Drug Supply Chain Security Act requirements.

Todd Branning, formerly Teva’s CFO, has joined Amneal as senior vice president and CFO.

Slayback’s generic Makena also is the first generic of Amag Pharmaceuticals’ drug in a multidose vial.

Samsung Bioepis has received its first approval for an oncology drug from the Food and Drug Administration, which has given the green light to the company's Ontruzant — a biosimilar of Herceptin.

The drug had a market size of roughly $2.5 billion for the 12 months ended September 2018, according to IQVIA data.

Walmart will continue to participate in CVS Caremark's PBM commercial and Managed Medicaid retail pharmacy networks, as well as Medicare Part D networks.